Arkolith/Insider Trading/ANGN/Form 4

Venkatesan Jay

See Remarks, DirectorAngion Biomedica Corp. (ANGN) · full profile →Form 4 · filed Dec 17, 2021
Net Buying
Open-Market Buys
$187K
Open-Market Sells
$0
Net Open-Market Flow
$187K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 15, 2021Buy(P)78K$2.41$187K1.3M
Jun 24, 2021Tax withholding(F)41K$13.78$566K1.2M

Transaction Codes

P
Open-market purchase
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001601485-21-000087) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Angion Biomedica Corp.

Build

Ask your agent about ANGN insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001601485-21-000087"
Ask your agent
Use Arkolith to summarize insider buying and selling at Angion Biomedica Corp.
over the last 90 days and cite the filings.